theyre illegal pharmaceutical companies. Ray Serrano, PhD, director of research and policy at the League of United Latin American Citizens, discussed how counterfeit GLP-1s can impact Black and Latino communities where families may not have health insurance that covers brand-name semaglutide or tirzepatide or they may not be able to afford the drug
For individuals seeking support with obesity or weight management, NICE-approved pathways exist and should be the starting point
Exclusivity on the peptides has proven robust because the claim protects the key peptide and, even though the generic scope may be limited, there is little structural room for a successful follow-on outside the claim
The addition of Ozempic to metformin has produced superior results compared to other combinations, including metformin
The phase 2 trial showed 17.1% average body weight reduction at 48 weeks with the 4mg dose
At Optimal Health Medical, GLP-1 weight loss is approached as part of a broader health plan, not as a one-size-fits-all prescription